Cargando…

Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients

Detalles Bibliográficos
Autores principales:	Telfer, Paul, de la Fuente, Josu, Sohal, Mamta, Brown, Ralph, Eleftheriou, Perla, Roy, Noémi, Piel, Frédéric B., Chakravorty, Subarna, Gardner, Kate, Velangi, Mark, Drasar, Emma, Shah, Farrukh, Porter, John B., Trompeter, Sara, Atoyebi, Wale, Szydlo, Richard, Anie, Kofi A., Ryan, Kate, Sharif, Joseph, Wright, Josh, Astwood, Emma, Nicolle, C. Sarah, Webster, Amy, Roberts, David J., Lugthart, Sanne, Kaya, Banu, Awogbade, Moji, Rees, David C., Hollingsworth, Rob, Inusa, Baba, Howard, Jo, Layton, D. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604629/ https://www.ncbi.nlm.nih.gov/pubmed/33054122 http://dx.doi.org/10.3324/haematol.2020.259440

Ejemplares similares

S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.
por: Lugthart, S, et al.
Publicado: (2022)

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
por: Rankine-Mullings, Angela, et al.
Publicado: (2023)

Biopsychosocial Predictors of Quality of Life in Paediatric Patients With Sickle Cell Disease
por: Hood, Anna M., et al.
Publicado: (2021)

PI-07: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: P., KOUNTOURIS, et al.
Publicado: (2022)

P1481: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATIVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES
por: Kountouris, P., et al.
Publicado: (2022)

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
por: Inusa, Baba P. D., et al.
Publicado: (2019)

White matter integrity and processing speed in sickle cell anemia
por: Stotesbury, Hanne, et al.
Publicado: (2018)

Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
por: Clayden, Jonathan D., et al.
Publicado: (2022)

P1448: CHARACTERISATION OF QUALITY OF LIFE-LINKED PATIENT-REPORTED OUTCOMES THROUGH A DIGITAL AND CONTINUOUS REMOTE MONITORING ECOSYSTEM IN SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

5609968 REAL-WORLD PATIENT-REPORTED OUTCOMES AND WEARABLE METRIC CORRELATIONS: REMOTE DAILY MONITORING FOR EXPLORATION OF QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
por: Inusa, Baba Psalm Duniya, et al.
Publicado: (2018)

Utilising the ‘Getting to Outcomes(®)’ Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria
por: Inusa, Baba P.D., et al.
Publicado: (2018)

Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial
por: Oakley, Laura L., et al.
Publicado: (2020)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Associations between environmental factors and hospital admissions for sickle cell disease
por: Piel, Frédéric B., et al.
Publicado: (2017)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

In utero hematopoietic cell transplantation for hemoglobinopathies
por: Derderian, S. Christopher, et al.
Publicado: (2015)

Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trial
por: Hood, Anna M., et al.
Publicado: (2021)

High body mass index in children with sickle cell disease: a retrospective single-centre audit
por: Hall, Rachael, et al.
Publicado: (2018)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

New approaches for cholestasis in hemoglobinopathies
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Hemoglobinopathies in Iran: An Updated Review
por: Nasiri, Abolfazl, et al.
Publicado: (2020)

5610692 PAIN BURDEN PREDICTS EXECUTIVE FUNCTION IN PAEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Chen, Y., et al.
Publicado: (2023)

Total hip arthroplasty in osteonecrosis secondary to sickle cell disease
por: Farook, Mohamed Zubair, et al.
Publicado: (2018)

Not being heard: barriers to high quality unplanned hospital care during young people’s transition to adult services – evidence from ‘this sickle cell life’ research
por: Renedo, Alicia, et al.
Publicado: (2019)

Sickle cell hemoglobinopathies in district Bhopal
por: Dangi, C. B. S., et al.
Publicado: (2010)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

Guidelines for screening, diagnosis and management of hemoglobinopathies
por: Ghosh, Kanjaksha, et al.
Publicado: (2014)

Hemoglobinopathy and pediatrics in the time of COVID-19
por: Vilela, Thiago de Souza, et al.
Publicado: (2021)

Hemoglobinopathies: ocular manifestations in children and adolescents
por: Moussa, Omar, et al.
Publicado: (2021)

COULD COVID-19 BE A HEMOGLOBINOPATHY?
por: Shakoori, Tania Ahmed, et al.
Publicado: (2020)

Endocrinopathies complicating transfusion-dependent hemoglobinopathy
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2020)

The hemoglobinopathies, molecular disease mechanisms and diagnostics
por: Harteveld, Cornelis L., et al.
Publicado: (2022)

Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?
por: Evangelidis, Paschalis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gus9v7ckgsmq0i9n3grsegdgr8